Hepatitis B Hepatitis B  Those with current cirrhosis are in most need of treatment. The use of interferon, which requires injections daily or thrice weekly, has been supplanted by long-acting PEGylated interferon, which is injected only once weekly.  However, some individuals are much more likely to respond than others, and this might be because of the genotype of the infecting virus or the person's heredity.  The treatment reduces viral replication in the liver, thereby reducing the viral load .  Response to treatment differs between the genotypes.  Interferon treatment may produce an e antigen seroconversion rate of 37% in genotype A but only a 6% seroconversion in type D.  Genotype B has similar seroconversion rates to type A while type C seroconverts only in 15% of cases Hepatitis B Hepatitis B